What is Aida Pharmaceuticals, Inc.'s annual revenue?

Aida Pharmaceuticals, Inc. (AIDA) reported annual revenue of $29.0M in its most recent fiscal year.

What is Aida Pharmaceuticals, Inc.'s net profit?

Aida Pharmaceuticals, Inc. (AIDA) reported net profit of $3.0M in its most recent fiscal year.

What is AIDA EV/EBITDA?

Aida Pharmaceuticals, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 3.41.

OTC · Financial Statements

Aida Pharmaceuticals, Inc. (AIDA) Financial Statements

$0.00 OTC: AIDA Market Cap $8101

Aida Pharmaceuticals, Inc. most recently reported annual revenue of $29.0M, net profit of $3.0M, revenue has compounded at 21.9% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2004	2005	2006	2007
Revenue	$16.0M	$25.0M	$30.0M	$29.0M
Operating Profit	$3.0M	$2.0M	$4.0M	$5.0M
Net Profit	$2.0M	$1.0M	$1.0M	$3.0M
EPS	$0.07	$0.06	$0.06	$0.10
Op Margin	18.3%	8.6%	13.3%	18.6%

Balance Sheet (USD)

Metric	2004	2005	2006	2007
Total Assets	—	$43.0M	$54.0M	$63.0M
Total Liabilities	—	$32.0M	$38.0M	$42.0M
Cash	—	$3.0M	$6.0M	$8.0M
Borrowings	$0	$25.0M	$30.0M	$33.0M

Cash Flow (USD)

Metric	2004	2005	2006	2007
Operating Cash Flow	—	$6.0M	$3.0M	$8.0M
Investing Cash Flow	—	$-5.0M	$-7.0M	$-15.0M
Financing Cash Flow	—	$-2.0M	$0	$1.0M
Net Cash Flow	—	$0	$3.0M	$2.0M
Free Cash Flow	$0	$5.0M	$0	$5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	3.41
FCF Yield	58985.69%
Quick Ratio	0.83
Interest Coverage	2.69
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

AIDA Overview AIDA Dividend Run Stock Screener